{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:57:44Z","timestamp":1790546264866,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["2021-13818\/SCR\/ADHOC-BMS"],"award-info":[{"award-number":["2021-13818\/SCR\/ADHOC-BMS"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SPG\/2021\/004179"],"award-info":[{"award-number":["SPG\/2021\/004179"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e36786","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T18:35:06Z","timestamp":1724438106000},"page":"e36786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Computational investigation of novel synthetic analogs of C-1\u2032\u03b2 substituted remdesivir against RNA-dependent RNA-polymerase of SARS-CoV-2"],"prefix":"10.1016","volume":"10","author":[{"given":"Savio","family":"Cardoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-0824","authenticated-orcid":false,"given":"Anirudh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6345-4569","authenticated-orcid":false,"given":"Souvik","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshatresh D.","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintu Kumar","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6146-937X","authenticated-orcid":false,"given":"Vibha","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e36786_bib1","series-title":"Molecular Virology of Human Pathogenic Viruses","first-page":"289","author":"Ryu","year":"2017"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36786_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/acsinfecdis.0c00646","article-title":"Recent insights into emerging coronavirus: SARS-CoV-2","volume":"7","author":"Shang","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e36786_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.antiviral.2018.11.016","article-title":"The evolution of antiviral nucleoside analogues: a review for chemists and non-chemists. Part II: complex modifications to the nucleoside scaffold","volume":"162","author":"Yates","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2024.e36786_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold","volume":"154","author":"Seley-Radtke","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2024.e36786_bib5","unstructured":"WHO WHO Recommends Highly Successful COVID-19 Therapy and Calls for Wide Geographical Distribution and Transparency from Originator."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36786_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19\u2014interim WHO solidarity trial results","volume":"384","author":"Consortium","year":"2021","journal-title":"New Engl. J. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36786_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acs.oprd.0c00233","article-title":"Quest for a COVID-19 cure by repurposing small-molecule drugs: mechanism of action, clinical development, synthesis at scale, and outlook for supply","volume":"24","author":"C","year":"2020","journal-title":"Org. Process Res. Dev."},{"issue":"6575","key":"10.1016\/j.heliyon.2024.e36786_bib8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36786_bib9","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/acs.jmedchem.2c00444","article-title":"Development of azaindole-based frameworks as potential antiviral agents and their future perspectives","volume":"65","author":"Urvashi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e36786_bib10","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.1021\/acs.chemrev.1c00965","volume":"122","author":"Gao","year":"2022","journal-title":"Chem Rev."},{"issue":"7819","key":"10.1016\/j.heliyon.2024.e36786_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36786_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/v10020076","article-title":"RNA dependent RNA polymerases: insights from structure, function and evolution","volume":"10","author":"Venkataraman","year":"2018","journal-title":"Viruses"},{"issue":"6498","key":"10.1016\/j.heliyon.2024.e36786_bib13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36786_bib15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.molcel.2021.01.035","article-title":"Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication","volume":"81","author":"Bravo","year":"2021","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/acscentsci.0c01242","article-title":"Modeling the binding mechanism of remdesivir, Favilavir, and ribavirin to SARS-CoV-2 RNA-dependent RNA polymerase","volume":"7","author":"Byl\u00e9hn","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"50","key":"10.1016\/j.heliyon.2024.e36786_bib17","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1021\/acs.jpcb.0c07312","article-title":"Remdesivir strongly binds to both RNA-dependent RNA polymerase and main protease of SARS-CoV-2: evidence from molecular simulations","volume":"124","author":"Nguyen","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.heliyon.2024.e36786_bib18","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.3389\/fmicb.2020.592908","article-title":"Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2","volume":"11","author":"Eweas","year":"2021","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36786_bib19","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1021\/acs.jproteome.0c00392","volume":"19","author":"Chien","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.heliyon.2024.e36786_bib20","doi-asserted-by":"crossref","first-page":"104591","DOI":"10.1016\/j.compbiomed.2021.104591","article-title":"In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs","volume":"135","author":"Mondal","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e36786_bib21","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e36786_bib22","series-title":"In Silico Evaluation of Isatin-Based Derivatives with RNA-dependent RNA Polymerase of the Novel Coronavirus SARS-CoV-2","author":"Kumar","year":"2021"},{"issue":"47","key":"10.1016\/j.heliyon.2024.e36786_bib23","doi-asserted-by":"crossref","first-page":"10641","DOI":"10.1021\/acs.jpcb.0c06747","article-title":"Revealing the inhibition mechanism of RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 by remdesivir and nucleotide analogues: a molecular dynamics simulation study","volume":"124","author":"Wakchaure","year":"2020","journal-title":"J. Phys. Chem. B"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36786_bib24","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/cr9002165","article-title":"C-nucleosides: synthetic strategies and biological applications","volume":"109","author":"\u0160tambask\u00fd","year":"2009","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36786_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0163-7258(00)00097-8","article-title":"Purine nucleoside phosphorylases: properties, functions, and clinical aspects","volume":"88","author":"Bzowska","year":"2000","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36786_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-3542(89)90072-7","article-title":"Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro","volume":"12","author":"Hosoya","year":"1989","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-3542(02)00013-X","article-title":"Identification of active antiviral compounds against a New York isolate of West Nile virus","volume":"55","author":"Morrey","year":"2002","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.11.008","article-title":"Ebola virus (EBOV) infection: therapeutic strategies","volume":"93","author":"De Clercq","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-3542(86)90039-2","article-title":"Comparative efficacy of broad-spectrum antiviral agents as inhibitors of rotavirus replication in vitro","volume":"6","author":"Kitaoka","year":"1986","journal-title":"Antivir. Res."},{"issue":"7496","key":"10.1016\/j.heliyon.2024.e36786_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36786_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.26.4.476","article-title":"Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses","volume":"26","author":"Huggins","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36786_bib32","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/jm970532z","article-title":"Synthesis and antiviral evaluation of certain novel pyrazinoic acid C-nucleosides","volume":"41","author":"Walker","year":"1998","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36786_bib33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of covid-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e36786_bib34","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1016\/j.bmcl.2014.05.015","article-title":"Preparation and biological evaluation of 1\u2032-cyano-2\u2032-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors","volume":"24","author":"Mish","year":"2014","journal-title":"Bioorg. Med. Chem.Lett."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36786_bib35","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a PhosphoramidateProdrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e36786_bib36","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1021\/acs.joc.3c00754","article-title":"Multistep synthesis of analogues of remdesivir: incorporating heterocycles at the C-1\u2032 position","volume":"88","author":"Cardoza","year":"2023","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101992","article-title":"High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance","volume":"24","author":"Padhi","year":"2021","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36786_bib38","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa - a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36786_bib39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e36786_bib40","series-title":"Schr\u00f6dinger Release 2023-3: QikProp","year":"2023"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36786_bib41","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for evaluating chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36786_bib42","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36786_bib43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36786_bib44","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e36786_bib45","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36786_bib46","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1529\/biophysj.107.114942","article-title":"Molecular dynamics simulations of hemoglobin A in different states and bound to dpg: effector-linked perturbation of tertiary conformations and HbA concerted dynamics","volume":"94","author":"Laberge","year":"2008","journal-title":"Biophys. J."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36786_bib47","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1080\/07391102.2021.1871956","article-title":"In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase","volume":"40","author":"Doharey","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36786_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/07391102.2020.1714481","article-title":"Structural heterogeneity in RNA recognition motif 2 (RRM2) of TAR DNA-binding protein 43 (TDP-43): clue to amyotrophic lateral sclerosis","volume":"39","author":"Prakash","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36786_bib49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e36786_bib50","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.heliyon.2024.e36786_bib51","series-title":"Schr\u00f6dinger Release 2023-3","year":"2023"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024128174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024128174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:16:05Z","timestamp":1790543765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024128174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":51,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024128174"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36786","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational investigation of novel synthetic analogs of C-1\u2032\u03b2 substituted remdesivir against RNA-dependent RNA-polymerase of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36786"}}